About
Data is a core asset in Life Science
Since the introduction of the internet and digital technologies the drug development industry has seen a continuous evolution of life sciences technologies. The fundamental currency that unlocks the value of life science technologies is data. Data is analyzed to generate insights, promote decisions, and build knowledge surrounding disease and drug development programs. The data therefore is a core asset to the organization. One could argue that data is just as valuable as the downstream therapeutic asset that it generates. This is the secret sauce and critical for regulatory compliance and future ideas for products.
Data Strategy
A proper Data Strategy sets the framework for how data will be collected, stored, and used. The strategy defines the organization principles for using data and the technology systems that will be used to build the data infrastructure. Without a data strategy, roadmap, and set of IT and data services, organizations will:
• never escape reactive mode
• risk losing data
• limit unlocking the value in their data
• raise the risk of non-compliance with regulatory requirements
• waste time & resources repeating experiments to regenerate data
Our Services
We offer a wide range of IT & Data consulting services, including:
- Research & Clinical Data Strategy
- IT Strategy for Biotechs
- Roadmap planning and execution
- Technology evaluation and selection
- Software Specialty Consulting on LIMS, ELN, and more
- Technology Executive Coaching